CEO and President of Bridgebio Pharma Inc (30-Year Financial, Insider Trades) Neil Kumar (insider trades) sold 80,000 shares of BBIO on 06/01/2020 at an average price of $29.19 a share. The total sale was $2.3 million.
BridgeBio Pharma Inc has a market cap of $3.5 billion; its shares were traded at around $28.86 with and P/S ratio of 83.67. GuruFocus has detected 1 severe warning sign with BridgeBio Pharma Inc. .
CEO Recent Trades:
- CEO and President Neil Kumar sold 80,000 shares of BBIO stock on 06/01/2020 at the average price of $29.19. The price of the stock has decreased by 1.13% since.
- CEO and President Neil Kumar sold 79,600 shares of BBIO stock on 05/05/2020 at the average price of $31.02. The price of the stock has decreased by 6.96% since.
Directors and Officers Recent Trades:
- See Remarks Brian C Stephenson sold 7,200 shares of BBIO stock on 06/01/2020 at the average price of $29.36. The price of the stock has decreased by 1.7% since.
- Chief Business Officer Michael Thomas Henderson sold 2,585 shares of BBIO stock on 06/01/2020 at the average price of $29.37. The price of the stock has decreased by 1.74% since.
- 10% Owner Genetic Disorder L.p. Kkr sold 2,389,690 shares of BBIO stock on 05/28/2020 at the average price of $33.39. The price of the stock has decreased by 13.57% since.
- See Remarks Michael Thomas Henderson sold 1,460 shares of BBIO stock on 05/05/2020 at the average price of $30.47. The price of the stock has decreased by 5.28% since.
- See Remarks Brian C Stephenson sold 5,706 shares of BBIO stock on 05/05/2020 at the average price of $30.49. The price of the stock has decreased by 5.35% since.
For the complete insider trading history of BBIO, click here
.
